<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-27T11:32:46+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>10年临床研究数据：CIK细胞能够显著提高无进展生存期和总体生存率丨医麦猛爆料</title>
    <updated>2020-11-26T17:49:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/6_bQwlXLdIPMv3_Ijwg0Tg</id>
    <link href="https://mp.weixin.qq.com/s/6_bQwlXLdIPMv3_Ijwg0Tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>快速发展的生物制药领域驱动CDMO产能不断扩大，如何全面评估最适合您需求的CDMO合作伙伴？丨星耀研究院</title>
    <updated>2020-11-26T17:49:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/ItzZ5UTyjI2K85Nt8YXcpQ</id>
    <link href="https://mp.weixin.qq.com/s/ItzZ5UTyjI2K85Nt8YXcpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李振宇教授：2020中国多发性骨髓瘤诊治指南亮点更新，推荐复发适合患者优先进入CAR-T研究</title>
    <updated>2020-11-26T17:49:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/i5_To3722zhdwFNz3nZTmg</id>
    <link href="https://mp.weixin.qq.com/s/i5_To3722zhdwFNz3nZTmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GD2抗体获得美国FDA批准上市，用于治疗高危神经母细胞瘤的儿童患者丨医麦猛爆料</title>
    <updated>2020-11-26T17:49:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/f_H2_UYCGhA30H7J0neUig</id>
    <link href="https://mp.weixin.qq.com/s/f_H2_UYCGhA30H7J0neUig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新通知丨生物医药生产工艺、质量控制与注册法规培训班</title>
    <updated>2020-11-26T17:49:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/nvFOBqvjNOtBhzcRa1TzyQ</id>
    <link href="https://mp.weixin.qq.com/s/nvFOBqvjNOtBhzcRa1TzyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」深圳因诺免疫常务副总经理王明军：肿瘤免疫治疗为本世纪最有希望彻底治愈癌症的一种疗法</title>
    <updated>2020-11-26T17:49:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/iQg188mG8EveFv3BR01iyQ</id>
    <link href="https://mp.weixin.qq.com/s/iQg188mG8EveFv3BR01iyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【视频】MSC如何培养？| 医麦猛爆料</title>
    <updated>2020-11-25T22:09:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/UaF7NSOvN5DLAxAgB6-8Mw</id>
    <link href="https://mp.weixin.qq.com/s/UaF7NSOvN5DLAxAgB6-8Mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>方达医药美国实验室推出快速COVID-19核酸及IgM抗体检测服务</title>
    <updated>2020-11-25T22:09:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/fsQLaleof52xnq30llHo0A</id>
    <link href="https://mp.weixin.qq.com/s/fsQLaleof52xnq30llHo0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>mRNA疫苗研发系列公开课第二场精彩回顾：安全性及免疫效力评价</title>
    <updated>2020-11-25T22:09:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/L_Yedoo2kKzv7feJO6MKjQ</id>
    <link href="https://mp.weixin.qq.com/s/L_Yedoo2kKzv7feJO6MKjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默克看好的4-1BB/PD-L1双特异性抗体获批临床，国内科望生物领跑丨医麦猛爆料</title>
    <updated>2020-11-25T22:09:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/1JSgKRfP0cSu74fQ54QRCQ</id>
    <link href="https://mp.weixin.qq.com/s/1JSgKRfP0cSu74fQ54QRCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」康希诺研发总监莘春林：扩大产能、均衡分配，将成为新冠疫苗的下一步挑战</title>
    <updated>2020-11-25T22:09:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/6QYAR72cKfLe_zFS4_1txQ</id>
    <link href="https://mp.weixin.qq.com/s/6QYAR72cKfLe_zFS4_1txQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>傅卫军教授：多发性骨髓瘤新型治疗药物研究推进，有望带来治疗策略的改变</title>
    <updated>2020-11-25T22:09:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/VTk6dkaYhnvCvYMbAT5awQ</id>
    <link href="https://mp.weixin.qq.com/s/VTk6dkaYhnvCvYMbAT5awQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>源兴基因，病毒载体商业化制备的引领者丨医麦猛爆料</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/SZlqcBNAp-Q_y449czxF2Q</id>
    <link href="https://mp.weixin.qq.com/s/SZlqcBNAp-Q_y449czxF2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>方达沙龙｜“药物研发生物分析和注册申报要点”广州站（第三轮通知）</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/qwN9bhLCpSq8M_wWVXd7OA</id>
    <link href="https://mp.weixin.qq.com/s/qwN9bhLCpSq8M_wWVXd7OA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>备受制药巨头和资本青睐的TCR领域，迎来首个积极的Ⅲ期临床结果丨医麦新观察</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/ANAMNg_N_neu7Oi_h9Uu8g</id>
    <link href="https://mp.weixin.qq.com/s/ANAMNg_N_neu7Oi_h9Uu8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>现货型CAR-NK新贵获4200万美元融资，NK细胞在癌症治疗领域的潜力大开发 | 医麦猛爆料</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/BZZQFXt_-XLP_t6wk5Zn6Q</id>
    <link href="https://mp.weixin.qq.com/s/BZZQFXt_-XLP_t6wk5Zn6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>热点解读｜Claudin 18.2-下一个肿瘤免疫治疗 / 伴随诊断新热点</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/A-IZwiWknD16jN5GdOg8Ig</id>
    <link href="https://mp.weixin.qq.com/s/A-IZwiWknD16jN5GdOg8Ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫情防控常态化，医疗策略精准化 | 2020 精准医学产业化（上海）高峰论坛圆满落幕</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/8XG_ZFi1cLk9lPhcnrAs3w</id>
    <link href="https://mp.weixin.qq.com/s/8XG_ZFi1cLk9lPhcnrAs3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>郝思国教授：双份脐血移植治疗恶性血液肿瘤疗效确切、复发率低，值得进一步临床对照研究</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/YPIfjkeXVfLvEYz_iK0b9A</id>
    <link href="https://mp.weixin.qq.com/s/YPIfjkeXVfLvEYz_iK0b9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」华盖医疗合伙人张翼：与药企共同成长，迈入国际一线阵营</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/syYfIK7ZPyJ7UlIvJMnMoA</id>
    <link href="https://mp.weixin.qq.com/s/syYfIK7ZPyJ7UlIvJMnMoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>